Hint mode is switched on Switch off

Edgewise Therapeutics, ordinary share
EWTX, US28036F1057

Add a stock to WL
Choose all Reset all
Edgewise Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Edgewise Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.
  • Issuer
  • Full borrower / issuer name
    Edgewise Therapeutics Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    EWTX
  • Placement
    26.03.2021
  • Lock up period
    180
  • Number of papers
    11,000,000
  • Volume of raised funds
    176 mln USD
  • Placement share
    23.13%
  • Final placement price
    16 USD
  • Price change since placement date
    -100%
  • By capitalization
    761.07 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    EWTX
  • Placement
    14.09.2022
  • Lock up period
    180
  • Number of papers
    11,627,907
  • Volume of raised funds
    120 mln USD
  • Placement share
    18.94%
  • Final placement price
    10.32 USD
  • Price change since placement date
    -100%
  • By capitalization
    633.73 mln USD

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

10/07/2026 Edgewise Therapeutics: Regulation Fddisclosure, Financial Statements And Exhibits
10/07/2026 Edgewise Therapeutics: Ofform8k. This Current Report On Form8k/ashould Be Read In Conjunction With The Initial Report, Which Provides A More Complete Description Of The Transaction
04/06/2026 Edgewise Therapeutics: Submission Of Matters To A Vote Of Security Holders
31/05/2026 Edgewise Therapeutics: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
19/11/2025 Edgewise Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.